Lu Cao

机构：University of Shanghai for Science and Technology, Tianjin Chengjian University, Peking University, Wenzhou Medical University, Ruijin Hospital, First Affiliated Hospital of Wenzhou Medical University, Kunshan Govisionox Optoelectronic (China), Affiliated Hospital of North Sichuan Medical College, Nanjing Drum Tower Hospital, Shanghai Institute of Materia Medica, Gallipoli Medical Research Foundation, Xi’an Children’s Hospital, Peking University Sixth Hospital, East China Normal University · ORCID：0000-0002-5159-7615

发表论文 80 篇 · 总被引 1203 次 · h-index 23

代表论文

• Adipose-derived stem cell exosome NFIC improves diabetic foot ulcers by regulating miR-204-3p/HIPK2 (2023 · Journal of Orthopaedic Surgery and Research · 被引 27)
• Cell cycle checkpoint revolution: targeted therapies in the fight against malignant tumors (2024 · Frontiers in Pharmacology · 被引 24)
• Smad2/3/4 complex could undergo liquid liquid phase separation and induce apoptosis through TAT in hepatocellular carcinoma (2024 · Cancer Cell International · 被引 10)
• Development and validation of an RBP gene signature for prognosis prediction in colorectal cancer based on WGCNA (2023 · Hereditas · 被引 9)
• The role of various collagen types in tumor biology: a review (2025 · Frontiers in Oncology · 被引 8)
• Application of multimodal standardized analgesia under the concept of enhanced recovery after surgery in laparoscopic radical colorectal cancer surgery (2024 · Frontiers in Oncology · 被引 8)